WallStSmart
COCP

Cocrystal Pharma Inc

NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY

$1.39
+0.00% today

Updated 2026-04-29

Market cap
$19.71M
P/E ratio
P/S ratio
92.45x
EPS (TTM)
$-0.78
Dividend yield
52W range
$1 – $2
Volume
3.0M

Cocrystal Pharma Inc (COCP) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-34166.00$-33577.00$-25099.00$-19345.00$-420953.00$-1.47M$-4.57M$-6.01M$-10.32M$-14.65M$-6.90M$-8.29M$-1.56M$-9.83M$-12.72M$-21.43M$-14.67M$-16.48M$-8.19M
Capital expenditures$0.00$1012.00$5200.00$5200.00$575430.00$374336.00$4.00$5000.00$339000.00$51000.00$40000.00$28000.00$145000.00$240000.00$52000.00$74000.00$118000.00$8000.00$12000.00
Depreciation
Stock-based comp$6.27M$120000.00$9.34M$38000.00$2.93M$548000.00$614000.00$562000.00$351000.00$662000.00$724000.00$855000.00$801000.00$643000.00$270000.00
Free cash flow$-34166.00$-34589.00$-30299.00$-24545.00$-996383.00$-1.85M$-4.57M$-6.01M$-10.66M$-14.71M$-6.94M$-8.32M$-1.71M$-10.07M$-12.77M$-21.51M$-14.78M$-16.49M$-8.20M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$581370.00$2.94M$5.31M$-5.64M$-2.86M$1.98M$4.72M$25.59M